Last reviewed · How we verify

NCT03701620: HRV-TBI

Heart Rate Variability in Children With Traumatic Brain Injury

Completed Last updated 6 October 2021
What this trial tests

trial testing HRV monitoring in Traumatic Brain Injury in 15 participants. Completed in 10 February 2021.

Timeline
1 January 2018
Primary endpoint
5 July 2019
10 February 2021

Quick facts

Lead sponsorSt. Justine's Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment15
Start date1 January 2018
Primary completion5 July 2019
Estimated completion10 February 2021
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

St. Justine's Hospital

Who can join

Adults 0 to 18, any sex, with Traumatic Brain Injury or Child Development. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Using a prospective cohort of children admitted to the PICU, the investigators will determine HRV monitoring is feasible, if a decreased HRV in the 7 days following moderate or severe TBI in children is associated with a worse outcome 6 months post-TBI and investigate HRV as a tool that can predict adverse events (neurological crisis) within 2 days following TBI.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Traumatic Brain Injury

Currently open trials in the same condition.

Other St. Justine's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03701620.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing